PYPD

Polypid Ltd.

• TipRanks·08/14 02:30

  Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)

• TipRanks·08/13 00:12

  PolyPid Earnings Call: Priority Review, Big Azurity Deal

• TipRanks·08/12 21:17

  PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline

• NASDAQ·08/12 18:45

  PolyPid Advances D-PLEX100; FDA Grants Priority Review

• TipRanks·08/12 16:50

  Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

• TipRanks·08/12 11:57

  PolyPid Wins FDA Priority Review for D-PLEX₁₀₀ and Locks In $30 Million Azurity Milestones

• Benzinga·08/12 11:30

  PolyPid Q2 EPS $(0.35) Beats $(0.38) Estimate

• Seeking Alpha·07/29 18:20

  PolyPid rises as lead product granted FDA priority review

• TipRanks·07/29 15:30

  PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital

• NASDAQ·07/29 14:55

  PolyPid's NDA For D-PLEX100 Receives FDA Priority Review, Stock Up

• TipRanks·07/29 13:01

  PolyPid announces FDA acceptance of, priority review for D-PLEX100

• TipRanks·07/29 12:57

  PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market

• Benzinga·07/29 12:34

  PolyPid Announces FDA Acceptance Of Its New Drug Application With A Priority Review For D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery; PDUFA Action Date Is November 28

• TipRanks·07/22 13:15

  PolyPid price target lowered to $12 from $13 at Craig-Hallum

• TipRanks·07/22 06:50

  Wall Street Analysts Are Bullish on Top Healthcare Picks